Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

PYR 41, Tocris Bioscience™

Catalog Number 297810
Click to view available options
10mg
This item is not returnable. View return policy
This item is not returnable. View return policy

Ubiquitin-activating enzyme (E1) inhibitor

Cell-permeable, irreversible ubiquitin-activating enzyme (E1) inhibitor (IC50 < 10 μM). Blocks ubiquitination and prevents ubiquitin-mediated proteasomal degradation. Inhibits NF-κB activation, blocks degradation of p53, increases p21 levels and induces apoptosis in vitro. Also causes an increase in sumoylation of proteins.
CAS 418805-02-4
Molecular Formula C17H13N3O7
Quantity 10 mg
Synonym pyr-41, pyr 41, pyr41, ubiquitin e1 inhibitor, pyr-41, ethyl 4-4z-4-5-nitrofuran-2-yl methylidene-3,5-dioxopyrazolidin-1-yl benzoate, benzoic acid, 4-4-5-nitro-2-furanyl methylene-3,5-dioxo-1-pyrazolidinyl-, ethyl ester, 4-4-5-nitro-furan-2-ylmethylene-3,5-dioxo-pyrazolidin-1-yl-benzoic acid ethyl ester, 4 4-5-nitro-furan-2-ylmethylene-3,5-dioxo-pyrazolidin-1-yl-benzoic acid ethyl ester
InChI Key ARGIPZKQJGFSGQ-LCYFTJDESA-N
SMILES CCOC(=O)C1=CC=C(C=C1)N2C(=O)C(=CC3=CC=C(O3)[N+](=O)[O-])C(=O)N2
IUPAC Name ethyl 4-[(4Z)-4-[(5-nitrofuran-2-yl)methylidene]-3,5-dioxopyrazolidin-1-yl]benzoate
Molecular Weight (g/mol) 371.305
PubChem CID 5335621
Formula Weight 371.3
Percent Purity >98%
Chemical Name or Material PYR 41
Show More Show Less
Recommended Storage Store at -20°C
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit